Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Neurofilament Proteins/blood"'
Autor:
Florian von Raison, Caroline Sincock, Robert J. Fox, Charlotte E. Teunissen, Douglas L. Arnold, Tatiana Plavina, David Leppert, Raju Kapoor, Kathryn E Smith, Jens Kuhle, Elizabeth Walker, Finn Sellebjerg, Roberto Furlan, Christopher Harp, Ilir Topalli, Mark Allegretta, Manuel Comabella, William Carroll
Publikováno v:
Kapoor, R, Smith, K E, Allegretta, M, Arnold, D L, Carroll, W, Comabella, M, Furlan, R, Harp, C, Kuhle, J, Leppert, D, Plavina, T, Sellebjerg, F, Sincock, C, Teunissen, C E, Topalli, I, von Raison, F, Walker, E & Fox, R J 2020, ' Serum neurofilament light as a biomarker in progressive multiple sclerosis ', Neurology, vol. 95, no. 10, pp. 436-444 . https://doi.org/10.1212/WNL.0000000000010346
Neurology, 95(10), 436-444. Lippincott Williams and Wilkins
Neurology
article-version (Version of Record) 3
Neurology, 95(10), 436-444. Lippincott Williams and Wilkins
Neurology
article-version (Version of Record) 3
There is an unmet need in multiple sclerosis (MS) therapy for treatments to stop progressive disability. The development of treatments may be accelerated if novel biomarkers are developed to overcome the limitations of traditional imaging outcomes re
Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab
Autor:
Fissolo, Nicolás, Pignolet, Beatrice, Rio, Jordi, Vermersch, Patrick, Ruet, Aurélie, deSèze, Jerome, Labauge, Pierre, Vukusic, Sandra, Papeix, Caroline, Martinez-Almoyna, Laurent, Tourbah, Ayman, Clavelou, Pierre, Moreau, Thibault, Pelletier, Jean, Lebrun-Frenay, Christine, Bourre, Bertrand, Defer, Gilles, Montalban, Xavier, Brassat, David, Comabella, Manuel, Universitat Autònoma de Barcelona
Publikováno v:
Neurology Neuroimmunology & Neuroinflammation
Neurology Neuroimmunology & Neuroinflammation, American Academy of neurology, 2021, 8 (4), pp.e1003. ⟨10.1212/NXI.0000000000001003⟩
Neurology Neuroimmunology & Neuroinflammation, 2021, 8 (4), pp.e1003. ⟨10.1212/NXI.0000000000001003⟩
Scientia
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Neurology® Neuroimmunology & Neuroinflammation
article-version (Version of Record) 3
Neurology Neuroimmunology & Neuroinflammation, American Academy of neurology, 2021, 8 (4), pp.e1003. ⟨10.1212/NXI.0000000000001003⟩
Neurology Neuroimmunology & Neuroinflammation, 2021, 8 (4), pp.e1003. ⟨10.1212/NXI.0000000000001003⟩
Scientia
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Neurology® Neuroimmunology & Neuroinflammation
article-version (Version of Record) 3
ObjectivesThe study aimed to assess the potential for serum neurofilament light chain (NFL) levels to predict the risk of progressive multifocal leukoencephalopathy (PML) in natalizumab (NTZ)-treated patients with multiple sclerosis (MS) and to discr
Autor:
Frederik Barkhof, Richard Dobson, Sebastiaan Engelborghs, Kristel Sleegers, Julius Popp, Anders Wallin, Rik Vandenberghe, Simon Lovestone, Giovanni B. Frisoni, Alberto Lleó, Lars Bertram, Alison L. Baird, Philip Scheltens, Cristina Legido-Quigley, Mara ten Kate, Pieter Jelle Visser, Pablo Martinez-Lage, Stephanie J.B. Vos, Christine Van Broeckhoven, José Luis Molinuevo, Henrik Zetterberg, Johannes Streffer, Isabelle Bos
Publikováno v:
Alzheimer's research & therapy
Alzheimer's Research & Therapy
Alzheimers Research & Therapy
Alzheimer's Research & Therapy, 10:64. BioMed Central Ltd
Alzheimer's Research and Therapy, Vol. 10, No 1 (2018) P. 64
Bos, I, Vos, S, Vandenberghe, R, Scheltens, P, Engelborghs, S, Frisoni, G, Molinuevo, J L, Wallin, A, Lleó, A, Popp, J, Martinez-Lage, P, Baird, A, Dobson, R, Legido-Quigley, C, Sleegers, K, Van Broeckhoven, C, Bertram, L, Ten Kate, M, Barkhof, F, Zetterberg, H, Lovestone, S, Streffer, J & Visser, P J 2018, ' The EMIF-AD Multimodal Biomarker Discovery study : design, methods and cohort characteristics ', Alzheimer's Research & Therapy, vol. 10, no. 1, pp. 64 . https://doi.org/10.1186/s13195-018-0396-5
Alzheimer's Research & Therapy, 10(1). BioMed Central
Alzheimer's research & therapy, vol. 10, no. 1, pp. 64
Alzheimer’s Research & Therapy, Vol 10, Iss 1, Pp 1-9 (2018)
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Alzheimer's Research & Therapy
Alzheimers Research & Therapy
Alzheimer's Research & Therapy, 10:64. BioMed Central Ltd
Alzheimer's Research and Therapy, Vol. 10, No 1 (2018) P. 64
Bos, I, Vos, S, Vandenberghe, R, Scheltens, P, Engelborghs, S, Frisoni, G, Molinuevo, J L, Wallin, A, Lleó, A, Popp, J, Martinez-Lage, P, Baird, A, Dobson, R, Legido-Quigley, C, Sleegers, K, Van Broeckhoven, C, Bertram, L, Ten Kate, M, Barkhof, F, Zetterberg, H, Lovestone, S, Streffer, J & Visser, P J 2018, ' The EMIF-AD Multimodal Biomarker Discovery study : design, methods and cohort characteristics ', Alzheimer's Research & Therapy, vol. 10, no. 1, pp. 64 . https://doi.org/10.1186/s13195-018-0396-5
Alzheimer's Research & Therapy, 10(1). BioMed Central
Alzheimer's research & therapy, vol. 10, no. 1, pp. 64
Alzheimer’s Research & Therapy, Vol 10, Iss 1, Pp 1-9 (2018)
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Background There is an urgent need for novel, noninvasive biomarkers to diagnose Alzheimer’s disease (AD) in the predementia stages and to predict the rate of decline. Therefore, we set up the European Medical Information Framework for Alzheimer’
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc6eedcdfeb2a25dcc0295bf4142b693
http://hdl.handle.net/10852/62181
http://hdl.handle.net/10852/62181
Autor:
Disanto, Giulio, Barro, Christian, Benkert, Pascal, Naegelin, Yvonne, Schädelin, Sabine, Giardiello, Antonella, Zecca, Chiara, Blennow, Kaj, Zetterberg, Henrik, Leppert, David, Kappos, Ludwig, Gobbi, Claudio, Kuhle, Jens, Lalive d'Epinay, Patrice, Swiss Multiple Sclerosis Cohort Study Group
Publikováno v:
Annals of Neurology
Annals of Neurology, Vol. 81, No 6 (2017) pp. 857-870
Annals of Neurology, Vol. 81, No 6 (2017) pp. 857-870
Objective Neurofilament light chains (NfL) are unique to neuronal cells, are shed to the cerebrospinal fluid (CSF), and are detectable at low concentrations in peripheral blood. Various diseases causing neuronal damage have resulted in elevated CSF c
Autor:
Maggi, Pietro, Kuhle, Jens, Schädelin, Sabine, van der Meer, Franziska, Weigel, Matthias, Galbusera, Riccardo, Mathias, Amandine, Lu, Po-Jui, Rahmanzadeh, Reza, Benkert, Pascal, La Rosa, Francesco, Bach Cuadra, Meritxell, Sati, Pascal, Théaudin, Marie, Pot, Caroline, Van Pesch, Vincent, Leppert, David, Stadelmann, Christine, Kappos, Ludwig, Du Pasquier, Renaud, Reich, Daniel S, Absinta, Martina, Granziera, Cristina
Publikováno v:
Neurology, vol. 97, no. 6, pp. e543-e553
Neurology, Vol. 97, no. 6, p. e543-e553 (2021)
Neurology, Vol. 97, no. 6, p. e543-e553 (2021)
To assess whether chronic white matter inflammation in patients with multiple sclerosis (MS) as detected in vivo by paramagnetic rim MRI lesions (PRLs) is associated with higher serum neurofilament light chain (sNfL) levels, a marker of neuroaxonal d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::807642d21e778120d2127380d71e9ba8
https://infoscience.epfl.ch/record/289248
https://infoscience.epfl.ch/record/289248